ArticleFrontiers in medicine2026
Clinical management of nanophthalmos combined with cataract: a case series.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Cataract and glaucoma surgery in microphthalmic, nanophthalmic, and high hyperopic eyes: a systematic review and meta-analysis.Frontiers in ophthalmology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To explore the clinical characteristics, surgical challenges, and management strategies for nanophthalmos combined with cataract. Case presentation: We report three adult patients with nanophthalmos, all presenting with extremely short axial lengths (Case 1: OD 14.83 mm, OS 14.54 mm; Case 2: OD 16.27 mm; Case 3: OD 15.19 mm, OS 15.00 mm) complicated by varying degrees of cataracts and other ocular complications. All three patients underwent phacoemulsification cataract extraction with intraocular lens implantation following admission. Conclusion: Patients with nanophthalmos face higher risks during cataract surgery compared to the general population, with a greater likelihood of postoperative complications such as uveal effusion syndrome, choroidal detachment, and a fibrotic membrane on the anterior IOL surface. Thorough perioperative assessment, meticulous surgical technique, individualized complication management, and long-term follow-up are critical to improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.